JP2014028787A5 - - Google Patents

Download PDF

Info

Publication number
JP2014028787A5
JP2014028787A5 JP2012199657A JP2012199657A JP2014028787A5 JP 2014028787 A5 JP2014028787 A5 JP 2014028787A5 JP 2012199657 A JP2012199657 A JP 2012199657A JP 2012199657 A JP2012199657 A JP 2012199657A JP 2014028787 A5 JP2014028787 A5 JP 2014028787A5
Authority
JP
Japan
Prior art keywords
keratinocytes
whitening agent
integrin
whitening
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012199657A
Other languages
Japanese (ja)
Other versions
JP6113981B2 (en
JP2014028787A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2012199657A priority Critical patent/JP6113981B2/en
Priority claimed from JP2012199657A external-priority patent/JP6113981B2/en
Publication of JP2014028787A publication Critical patent/JP2014028787A/en
Publication of JP2014028787A5 publication Critical patent/JP2014028787A5/ja
Application granted granted Critical
Publication of JP6113981B2 publication Critical patent/JP6113981B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (14)

角化細胞(ケラチノサイト、keratinocyte)の細胞接着抑制作用を指標とし美白剤を選択する、美白剤のスクリーニング方法。 Keratinocytes (keratinocytes, keratinocyte) selects a whitening agent and an indicator cell adhesion inhibitory effect, the screening method of whitening. 角化細胞の細胞接着抑制作用を評価する工程を含
前記工程は、被験物質を添加した角化細胞、及び被験物質を添加しない角化細胞において、角化細胞のインテグリン産生抑制作用、角化細胞の基底膜への接着抑制作用、及び角化細胞の上層移動促進作用からなる群より選択される1種又は2種以上の作用を比較することにより行われ
被験物質を添加した角化細胞における前記作用が、該被験物質を添加しない角化細胞よりも大きい場合に、該被験物質を美白剤として選択する、請求項1に記載の美白剤のスクリーニング方法。
The step of evaluating the cell adhesion inhibitory action of keratinocytes seen including,
The process, keratinocytes were added a test substance, and in keratinocytes without addition of the test substance, integrin production inhibitory effect of keratinocytes, adhesion inhibitory action to the basal membrane of keratinocytes, and keratinocytes It is performed by comparing one or more kinds of actions selected from the group consisting of the upper layer movement promoting action,
The whitening agent screening method according to claim 1 , wherein the test substance is selected as a whitening agent when the action on the keratinocytes to which the test substance is added is greater than that of the keratinocytes to which the test substance is not added .
角化細胞に細胞接着促進因子を付与する工程を含む、請求項2に記載の美白剤のスクリーニング方法。 The method for screening a whitening agent according to claim 2 , comprising a step of imparting a cell adhesion promoting factor to keratinocytes . 前記細胞接着促進因子が、メラニン及び/又はその関連物質である、請求項3に記載の美白剤のスクリーニング方法。   The whitening agent screening method according to claim 3, wherein the cell adhesion promoting factor is melanin and / or a substance related thereto. 前記角化細胞のインテグリン産生抑制作用が、インテグリンα6及び/又はβ4遺伝子発現抑制作用である、請求項〜4の何れか1項に記載の美白剤のスクリーニング方法。 The whitening agent screening method according to any one of claims 2 to 4, wherein the integrin production inhibitory action of keratinocytes is an integrin alpha 6 and / or beta 4 gene expression inhibitory action. 前記インテグリンα6及び/又はβ4遺伝子発現抑制作用が、インテグリンα6及び/又はβ4mRNA発現抑制作用である、請求項5に記載の美白剤のスクリーニング方法。   The whitening agent screening method according to claim 5, wherein the integrin α6 and / or β4 gene expression inhibitory effect is an integrin α6 and / or β4 mRNA expression inhibitory effect. 前記角化細胞のインテグリン産生抑制作用が、インテグリンα6及び/又はβ4蛋白発現抑制作用である、請求項〜4の何れか1項に記載の美白剤のスクリーニング方法。 The method for screening a whitening agent according to any one of claims 2 to 4, wherein the integrin production inhibitory effect of keratinocytes is an integrin α6 and / or β4 protein expression inhibitory effect. 前記角化細胞の基底膜への接着抑制作用が、ラミニン−5(Laminin−5)に対する角化細胞の接着抑制作用である、請求項〜4の何れか1項に記載の美白剤のスクリーニング方法。 The whitening agent screening according to any one of claims 2 to 4, wherein the inhibitory action of keratinocytes on the basement membrane is an inhibitory action of keratinocytes on Laminin-5. Method. 請求項1〜8の何れか1項に記載の美白剤のスクリニング方法を行う工程、及び前記工程により選択された美白剤を含有させることを含む、美白用組成物の設計方法 Step performs subscription over training method whitening agent according to any one of claims 1 to 8, and also contain a whitening agent selected by the process, the design method of whitening composition. 前記美白用組成物が皮膚外用剤である、請求項9に記載の設計方法The design method according to claim 9, wherein the whitening composition is an external preparation for skin. 前記美白用組成物が化粧料(但し、医薬部外品を含む)である、請求項9又は10に記載の設計方法The design method according to claim 9 or 10, wherein the whitening composition is a cosmetic (including a quasi-drug). 角化細胞の細胞接着抑制剤よりなる、美白剤。   A whitening agent comprising a cell adhesion inhibitor for keratinocytes. 前記角化細胞の細胞接着抑制剤は、角化細胞のインテグリン産生抑制作用、角化細胞の基底膜への接着抑制作用、及び角化細胞の上層移動促進作用から選択される作用の1種又は2種以上を有する、請求項12に記載の美白剤。   The cell adhesion inhibitor of keratinocytes is one or more kinds of actions selected from the action of inhibiting keratinocyte integrin production; The whitening agent of Claim 12 which has 2 or more types. 請求項12又は13に記載の美白剤を含有する皮膚外用剤。   A skin external preparation containing the whitening agent according to claim 12 or 13.
JP2012199657A 2012-06-29 2012-09-11 Screening method Active JP6113981B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012199657A JP6113981B2 (en) 2012-06-29 2012-09-11 Screening method

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012146197 2012-06-29
JP2012146197 2012-06-29
JP2012199657A JP6113981B2 (en) 2012-06-29 2012-09-11 Screening method

Publications (3)

Publication Number Publication Date
JP2014028787A JP2014028787A (en) 2014-02-13
JP2014028787A5 true JP2014028787A5 (en) 2015-06-25
JP6113981B2 JP6113981B2 (en) 2017-04-12

Family

ID=50201648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012199657A Active JP6113981B2 (en) 2012-06-29 2012-09-11 Screening method

Country Status (1)

Country Link
JP (1) JP6113981B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6763497B1 (en) * 2020-03-25 2020-09-30 大正製薬株式会社 Mineral metabolism disorder inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005013885A2 (en) * 2003-08-07 2005-02-17 Healor Ltd. Pharmaceutical compositions and methods for accelerating wound healing
JPWO2005056751A1 (en) * 2003-12-12 2007-07-05 株式会社日立メディコ Stem cell concentration apparatus and concentration method
JP5014569B2 (en) * 2004-09-16 2012-08-29 オリザ油化株式会社 Skin care composition
JP2008127357A (en) * 2006-11-22 2008-06-05 Konan Kako Kk External agent composition for skin
JP5787285B2 (en) * 2010-09-06 2015-09-30 公立大学法人大阪市立大学 Fibroblast proliferation promoter, keratinocyte migration / proliferation promoter, elastin production promoter, heat shock protein 47 production promoter, α-smooth muscle actin (α-SMA) production promoter, and photoaging inhibitor.

Similar Documents

Publication Publication Date Title
FR2964565B1 (en) COSMETIC COMPOSITION COMPRISING A FIXING POLYMER AND ANTIPELLICULAR AGENT
FR2962043B1 (en) COSMETIC COMPOSITION COMPRISING PEBA
JP2011037847A5 (en)
CA2851316C (en) Genes and proteins for alkanoyl-coa synthesis
BR112014017784A8 (en) ACTIVITY AND INACTIVITY MONITORING
WO2012003360A3 (en) Detergent product
MX343108B (en) Fabric care compositions comprising organosiloxane polymers.
ATE461699T1 (en) IMPROVED BIOLOGICAL EFFECTS OF COMPOSITIONS CONTAINING ROSMARIC ACID
WO2014096418A3 (en) Micrornas as therapeutics and biomarkers for epilepsy
WO2012131083A8 (en) Composition comprising perlite and a polymer bearing a carbosiloxane dendrimer-based unit
BR112013004124A2 (en) alpha2 integrin-binding peptide or peptide complex and methods and uses involving them
MX2017002469A (en) Extracellular matrix compositions.
JP2012236016A5 (en)
WO2012035120A3 (en) Screening method
US9568467B2 (en) Inhibitors of micro-RNAs for use for preventing and/or attenuating skin ageing
JP2014511827A5 (en)
JP2014028787A5 (en)
WO2014177867A3 (en) Differentially expressed biomarkers for alzheimer's disease
JP2015180198A5 (en)
WO2011003665A3 (en) Method of treating hair
JP2014048235A5 (en)
MX2015017535A (en) Treatment of insulin resistance through inhibitors of transcription factor tsc22d4.
JP2016063784A5 (en)
FR2927331B1 (en) NOVEL ANTI-INFECTIOUS DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THERAPEUTICS
JP2020510611A5 (en)